Impact of Chronic Kidney Disease in Patients Undergoing Percutaneous Coronary Intervention: Improved but Not Solved.
作者信息
Ryu Jae Kean, Lee In Hee
机构信息
Division of Cardiology, Department of Internal Medicine, Catholic University of Daegu, School of Medicine, Daegu, Korea.
Division of Nephrology, Department of Internal Medicine, Catholic University of Daegu, School of Medicine, Daegu, Korea.
出版信息
Korean Circ J. 2017 Mar;47(2):176-178. doi: 10.4070/kcj.2017.0013. Epub 2017 Mar 8.
Abstract
摘要
相似文献
1
Impact of Chronic Kidney Disease in Patients Undergoing Percutaneous Coronary Intervention: Improved but Not Solved.慢性肾脏病对接受经皮冠状动脉介入治疗患者的影响：有所改善但问题仍未解决。
Korean Circ J. 2017 Mar;47(2):176-178. doi: 10.4070/kcj.2017.0013. Epub 2017 Mar 8.
2
Clinical outcomes of treatment by percutaneous coronary intervention versus coronary artery bypass graft surgery in patients with chronic kidney disease undergoing index revascularization in Ontario.安大略省慢性肾病患者首次血运重建时经皮冠状动脉介入治疗与冠状动脉搭桥手术的临床结局
Circ Cardiovasc Interv. 2015 Jan;8(1). doi: 10.1161/CIRCINTERVENTIONS.114.001973.
3
Prevalence of chronic kidney disease among patients undergoing transradial percutaneous coronary interventions.经桡动脉冠状动脉介入治疗患者中慢性肾脏病的患病率
J Vasc Access. 2018 Jul;19(4):346-349. doi: 10.1177/1129729817752874. Epub 2018 Mar 12.
4
Optimal Treatment Strategies in Patients with Chronic Kidney Disease and Coronary Artery Disease.慢性肾脏病和冠状动脉疾病患者的最佳治疗策略。
Am J Med. 2016 Dec;129(12):1288-1298. doi: 10.1016/j.amjmed.2016.06.046. Epub 2016 Jul 28.
5
Impact of Chronic Kidney Disease on Cardiovascular and Renal Events in Patients Undergoing Percutaneous Coronary Intervention with Everolimus-Eluting Stent: Risk Stratification with C-Reactive Protein.经皮冠状动脉介入治疗中应用依维莫司洗脱支架的患者中慢性肾脏病对心血管和肾脏事件的影响：C 反应蛋白的风险分层。
Cardiorenal Med. 2018;8(2):151-159. doi: 10.1159/000486971. Epub 2018 Mar 27.
6
Outcomes after percutaneous coronary intervention for chronic total occlusion according to baseline renal function.根据基线肾功能评估经皮冠状动脉介入治疗慢性完全闭塞的结果。
Clin Res Cardiol. 2018 Mar;107(3):259-267. doi: 10.1007/s00392-017-1179-x. Epub 2017 Nov 13.
7
Association of contrast-induced acute kidney injury with long-term cardiovascular events in acute coronary syndrome patients with chronic kidney disease undergoing emergent percutaneous coronary intervention.对比剂诱导的急性肾损伤与行急诊经皮冠状动脉介入治疗的慢性肾脏病急性冠状动脉综合征患者长期心血管事件的相关性。
Int J Cardiol. 2014 Jun 1;174(1):57-63. doi: 10.1016/j.ijcard.2014.03.146. Epub 2014 Mar 28.
8
Incidence, Patterns, and Impact of Dual Antiplatelet Therapy Cessation Among Patients With and Without Chronic Kidney Disease Undergoing Percutaneous Coronary Intervention: Results From the PARIS Registry (Patterns of Non-Adherence to Anti-Platelet Regimens in Stented Patients).接受经皮冠状动脉介入治疗的慢性肾脏病患者和非慢性肾脏病患者中断双联抗血小板治疗的发生率、模式和影响：PARIS 登记研究（支架置入患者抗血小板治疗方案不依从模式）的结果。
Circ Cardiovasc Interv. 2018 Mar;11(3):e006144. doi: 10.1161/CIRCINTERVENTIONS.117.006144.
9
Assessing and minimizing the risk of percutaneous coronary intervention in patients with chronic kidney disease.评估并降低慢性肾脏病患者经皮冠状动脉介入治疗的风险
Expert Rev Cardiovasc Ther. 2018 Nov;16(11):825-835. doi: 10.1080/14779072.2018.1526082. Epub 2018 Oct 16.
10
In-Hospital Outcomes of Chronic Total Occlusion Percutaneous Coronary Intervention in Patients With Chronic Kidney Disease.慢性肾脏病患者慢性完全闭塞性经皮冠状动脉介入治疗的院内结局
J Invasive Cardiol. 2018 Nov;30(11):E113-E121. Epub 2018 Sep 15.
本文引用的文献
1
Impact of Chronic Kidney Disease on Clinical Outcomes in Diabetic Patients Undergoing Percutaneous Coronary Intervention in the Era of Newer-Generation Drug-Eluting Stents.新一代药物洗脱支架时代，慢性肾脏病对接受经皮冠状动脉介入治疗的糖尿病患者临床结局的影响。
Korean Circ J. 2017 Mar;47(2):222-230. doi: 10.4070/kcj.2016.0312. Epub 2017 Mar 13.
2
Impact of Chronic Kidney Disease on Long-Term Outcome in Coronary Bypass Candidates Treated with Percutaneous Coronary Intervention.慢性肾脏病对接受经皮冠状动脉介入治疗的冠状动脉搭桥术候选患者长期预后的影响。
Korean Circ J. 2017 Jan;47(1):50-55. doi: 10.4070/kcj.2016.0093. Epub 2016 Dec 12.
3
Relation of contrast-induced nephropathy to long-term mortality after percutaneous coronary intervention.对比剂肾病与经皮冠状动脉介入治疗后长期死亡率的关系。
Am J Cardiol. 2014 Aug 1;114(3):362-8. doi: 10.1016/j.amjcard.2014.05.009. Epub 2014 May 16.
4
Haemostasis in chronic kidney disease.慢性肾脏病的止血治疗。
Nephrol Dial Transplant. 2014 Jan;29(1):29-40. doi: 10.1093/ndt/gft209. Epub 2013 Oct 16.
5
Moderate-severe renal insufficiency is a risk factor for sirolimus-eluting stent thrombosis. The RIFT study.中重度肾功能不全是西罗莫司洗脱支架血栓形成的一个危险因素。RIFT研究。
Cardiology. 2009;112(3):191-9. doi: 10.1159/000149571. Epub 2008 Aug 1.
6
Causes and consequences of chronic kidney disease: implications for managed health care.慢性肾脏病的病因及后果：对管理式医疗保健的影响
J Manag Care Pharm. 2007 Apr;13(3 Suppl):S1-9. doi: 10.18553/jmcp.2007.13.s3.1.
7
Diabetic nephropathy, percutaneous coronary interventions, and blockade of the renin-angiotensin system.糖尿病肾病、经皮冠状动脉介入治疗与肾素-血管紧张素系统阻断
Cardiology. 2005;104(1):24-30. doi: 10.1159/000086050. Epub 2005 May 29.
8
Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention.肾病作为心血管疾病发生的危险因素：美国心脏协会心血管疾病中的肾脏、高血压研究、临床心脏病学以及流行病学与预防委员会的声明
Hypertension. 2003 Nov;42(5):1050-65. doi: 10.1161/01.HYP.0000102971.85504.7c.
9
Renal insufficiency and subsequent death resulting from cardiovascular disease in the United States.美国的肾功能不全以及由心血管疾病导致的后续死亡。
J Am Soc Nephrol. 2002 Mar;13(3):745-753. doi: 10.1681/ASN.V133745.
10
Are patients with renal failure good candidates for percutaneous coronary revascularization in the new device era?在新器械时代，肾衰竭患者是否适合接受经皮冠状动脉血运重建术？
Circulation. 2000 Dec 12;102(24):2966-72. doi: 10.1161/01.cir.102.24.2966.
Zotero 插件